Weave Bio and Takeda cut IND drafting time by 97% in AI regulatory trial
A new collaboration between the two companies shows measurable speed gains in submission preparation, with human oversight kept firmly in place
GSK moves its mRNA flu vaccine into late-stage trials after promising mid-stage results
A dual-protein approach sets GSK's candidate apart from Moderna's recently approved shot, and the race to redefine flu vaccination is now very much on
Dyson’s CameraJet toothbrush uses AI and a built-in camera to find and flush plaque...
Six years in development, the CameraJet combines a macro lens, machine learning, and a precision fluid jet — all in one device
Zaina launches Arabic-language AI assistant for aesthetic medicine in Saudi Arabia and Qatar
The platform has been operating across the Kingdom and Qatar since the summer, used by thousands of people considering procedures...
More than half the world would use AI for mental health support, new survey...
A large global study reveals striking public trust in ChatGPT-style tools for counselling, friendship, and even medical advice — but researchers are urging caution
Moderna and Merck’s personalized cancer vaccine hits its Phase 3 target in melanoma
A positive late-stage trial result for mRNA-based cancer immunotherapy sends Moderna's stock up nearly 150% — and raises real questions about what comes next for oncology
AI demand forecasting is fixing medicine shortages in Sierra Leone
A low-cost tool built by Wharton and Penn Engineering researchers is helping Sierra Leone's government get the right drugs to the right clinics — by predicting need and cleaning up messy data
Samsung’s Galaxy Buds just became FDA-cleared hearing aids
A software update to existing earbuds could reach more people with mild hearing loss than the entire global hearing aid market currently does
Karoo Health raises $16.2M to fix cardiac care’s fragmentation problem
The Albuquerque-based company already reports a 40% drop in ED visits across deployed programs
Cheiron raises $8M to build an operating system for drug programs
The AI platform wants to give biopharma teams a single, structured view of everything that shapes a drug program — from evidence to risk to regulatory history